Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 300
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- 50%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Longport, Inc. develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States. It offers EPISCAN I-200, a high frequency ultrasound imaging system that utilizes ultrasound at frequencies between 20 and 50MHz to image the skin and underlying soft tissue. The company's products are used in wound assessment, wound prevention, dermatology, and aesthetics/plastics, as...
Show more
Longport, Inc. develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States. It offers EPISCAN I-200, a high frequency ultrasound imaging system that utilizes ultrasound at frequencies between 20 and 50MHz to image the skin and underlying soft tissue. The company's products are used in wound assessment, wound prevention, dermatology, and aesthetics/plastics, as well as in various other applications. It also exports its products. The company was founded in 1993 and is based in Chadds Ford, Pennsylvania.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 610-361-9100
- Website
- https://www.longportinc.com
- Address
- 1620 Baltimore Pike, PO Box 768, Chadds Ford, United States
Latest news
No headlines yet.
